| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 29 |
| 1 | FLUDARABINE PHOSPHATE | 27 |
| 2 | TACROLIMUS | 26 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 25 |
| 4 | TACROLIMUS OINTMENT 0.1% | 25 |
| 5 | ALEMTUZUMAB | 17 |
| 6 | DEXAMETHASONE | 16 |
| 7 | DEXAMETHASONE 1.5 MG | 16 |
| 8 | PREDNISONE | 16 |
| 9 | DEFEROXAMINE MESYLATE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CIDOFOVIR ANHYDROUS | 10 | 0.0069 |
| 1 | DEFEROXAMINE MESYLATE | 14 | 0.0064 |
| 2 | TREOSULFAN | 14 | 0.0051 |
| 3 | MARIBAVIR | 10 | 0.0041 |
| 4 | LETERMOVIR | 10 | 0.0031 |
| 5 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 13 | 0.0016 |
| 6 | THIOTEPA | 14 | 0.0014 |
| 7 | FOSTAMATINIB | 11 | 0.0014 |
| 8 | GANCICLOVIR SODIUM | 10 | 0.0009 |
| 9 | ALEMTUZUMAB | 17 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 33 |
| 1 | Corticosteroid [EPC] | 31 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 29 |
| 3 | Kinase Inhibitor [EPC] | 18 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 17 |
| 5 | Immunoglobulin G [EPC] | 13 |
| 6 | Janus Kinase Inhibitor [EPC] | 13 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 13 |
| 8 | Azole Antifungal [EPC] | 11 |
| 9 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 10 | 0.0041 |
| 1 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 10 | 0.0031 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 17 | 0.0009 |
| 3 | Interleukin-1 Receptor Antagonist [EPC] | 10 | 0.0006 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 10 | 0.0004 |
| 5 | Thrombopoietin Receptor Agonist [EPC] | 4 | 0.0003 |
| 6 | Alkylating Drug [EPC] | 33 | 0.0001 |
| 7 | Nucleoside Analog Antiviral [EPC] | 10 | 0.0001 |
| 8 | Rifamycin Antibacterial [EPC] | 4 | 0.0001 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 29 | 0.0001 |